NCT00961025View on ClinicalTrials.gov

A Study to Characterize the Pharmacokinetics/Pharmacodynamics and Effect of Food of DA-1229 in Healthy Male Subjects

PHASE1UnknownINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

February 28, 2010

Study Completion Date

March 31, 2010

Conditions
Diabetes Mellitis Type 2
Interventions
DRUG

DA-1229

"single dose study : DA-1229 1.25,2.5,5,10,20,40,60mg~multiple dose study : DA-1229 5,10,20,40mg"

DRUG

Placebo

placebo

Trial Locations (1)

110-744

RECRUITING

Clinical Trials Center, Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Dong-A Pharmaceutical Co., Ltd.

INDUSTRY